Source author record

Kehan Wu

Kehan Wu appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Biomolecules eess.SP Machine Learning

Catalog footprint

What is connected

2works

3topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2024arXiv

Passive Respiration Detection via mmWave Communication Signal Under Interference

Recent research has highlighted the detection of human respiration rate using commodity WiFi devices. Nevertheless, these devices encounter challenges in accurately discerning human respiration amidst the prevailing human motion interference encountered in daily life. To tackle this predicament, this paper introduces a passive sensing and communication system designed specifically for respiration detection in the presence of robust human motion interference. Operating within the 60.48 GHz band, the proposed system aims to detect human respiration even when confronted with substantial human motion interference within close proximity. Subsequently, a neural network is trained using the collected data by us to enable human respiration detection. The experimental results demonstrate a consistently high accuracy rate over 90\% of the human respiration detection under interference, given an adequate sensing duration. Finally, an empirical model is derived analytically to achieve the respiratory rate counting in 10 seconds.

preprint2022arXiv

Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design

Structure-based drug design is drawing growing attentions in computer-aided drug discovery. Compared with the virtual screening approach where a pre-defined library of compounds are computationally screened, de novo drug design based on the structure of a target protein can provide novel drug candidates. In this paper, we present a generative solution named TamGent (Target-aware molecule generator with Transformer) that can directly generate candidate drugs from scratch for a given target, overcoming the limits imposed by existing compound libraries. Following the Transformer framework (a state-of-the-art framework in deep learning), we design a variant of Transformer encoder to process 3D geometric information of targets and pre-train the Transformer decoder on 10 million compounds from PubChem for candidate drug generation. Systematical evaluation on candidate compounds generated for targets from DrugBank shows that both binding affinity and drugability are largely improved. TamGent outperforms previous baselines in terms of both effectiveness and efficiency. The method is further verified by generating candidate compounds for the SARS-CoV-2 main protease and the oncogenic mutant KRAS G12C. The results show that our method not only re-discovers previously verified drug molecules , but also generates novel molecules with better docking scores, expanding the compound pool and potentially leading to the discovery of novel drugs.